Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher ...

Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Cardinal Health, Inc. CAH is scheduled to report fiscal second-quarter 2025 results on Jan. 30, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 14.

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Cardinal Health's pharmaceutical and specialty solutions segment profit increased 7% to $531 million in the second quarter.

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...

distributing pharmaceuticals and medical products to over 60,000 locations daily. At the helm of technology and business services is Michelle Greene, Cardinal Health’s Chief Information Officer ...